# Vaccination Against Influenza Pre-discharge in Heart Failure

Study · id `cardio:ct-nct06725927` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06725927](<https://clinicaltrials.gov/study/NCT06725927>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06725927

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 200 participants.

## Technical summary

Registry record NCT06725927. Randomized; no masking; primary purpose prevention. Start 2024-12-31 (actual); primary completion 2025-11-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT06725927, source copy `cardio:ctgov-nct06725927-2025-07-23`, retrieved 2026-10-26)
- Started: 2024-12-31 (actual) (ClinicalTrials.gov record NCT06725927, source copy `cardio:ctgov-nct06725927-2025-07-23`, retrieved 2026-10-26)
- Primary completion: 2025-11-30 (anticipated) (ClinicalTrials.gov record NCT06725927, source copy `cardio:ctgov-nct06725927-2025-07-23`, retrieved 2026-10-26)
- Completion: 2025-12 (anticipated) (ClinicalTrials.gov record NCT06725927, source copy `cardio:ctgov-nct06725927-2025-07-23`, retrieved 2026-10-26)
- Countries: Poland (ClinicalTrials.gov record NCT06725927, source copy `cardio:ctgov-nct06725927-2025-07-23`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06725927-2025-07-23`, retrieved 2026-10-26)

## The registry's words

- Brief title: Vaccination Against Influenza Pre-discharge in Heart Failure
- Condition: Heart Failure
- Intervention (Biological): Influenza vaccination
- Lead sponsor: Wroclaw Medical University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: Wroclaw Medical University (`cardio:org-wroclaw-medical-university`)

## Provenance

Content hash: 8a18eda415d61ae548d1f778d476a329be019e718e8b17ababe3a0f108ced9c8
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
